Natus Medical (NTUS)

Natus Medical Incorporated is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.

Company profile

Ticker

NTUS

Exchange

NASDAQ

Website

www.natus.com

CEO

Jonathan Kennedy

Incorporated

Delaware

Location

Wisconsin

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Electromedical & Electrotherapeutic Apparatus

Medtronic • Varian Medical Systems • Conmed • Masimo • LivaNova • Outset Medical • Fonar • Cutera • Inmode • Star Equity ...

SEC CIK

0000878526

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Natus Manufacturing Limited • Natus Medical Denmark ApS • Excel-Tech Corp. ...

IRS number

770154833

NTUS stock data

1M 1Y 5Y

News

From Benzinga Pro

Natus Medical Q1 EPS $0.22 Misses $0.26 Estimate, Sales $119.80M Beat $115.70M Estimate

5 May 22

Natus Medical (NASDAQ:NTUS) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.26 by 15.38 percent. This is a 37.5 percent increase over earnings of $0.16 per share from the

Earnings Scheduled For May 5, 2022

5 May 22

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

68 Biggest Movers From Yesterday

19 Apr 22

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core network functions.

Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide

18 Apr 22

12 Health Care Stocks Moving In Monday's Intraday Session

18 Apr 22

Press releases

From Benzinga Pro

INVESTIGATION NOTICE: Halper Sadeh LLP Investigates USWS, GDST, NTUS, CMAX

23 Jun 22

NEW YORK, June 23, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties

Shareholder Alert - The M&A Class Action Firm is Investigating the Merger - BKEP, PSB, SREV, NTUS, SAIL

22 Jun 22

NEW YORK , June 22, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates TREC, CVET, NTUS

7 Jun 22

NEW YORK, June 7, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties

NATUS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS

6 Jun 22

SHAREHOLDER UPDATE: Halper Sadeh LLP Investigates CMAX, TVTY, GTYH, NTUS

2 Jun 22

Calendar

6 May 22

2 Jul 22

31 Dec 22

Financial summary

Financial statements Chart NTUS financial data

Quarter (USD)	Mar 22	Dec 21	Sep 21	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Recent insider trades

NTUS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	#Shares	#Remaining
15 Jun 22	Daskal Ilan	Common Stock, $0.001 par value per share	Grant	Acquire A	No	No	5,075	18,937
15 Jun 22	Eric Guerin	Common Stock, $0.001 par value per share	Grant	Acquire A	No	No	4,315	10,114
15 Jun 22	Heine Lisa Wipperman	Common Stock, $0.001 par value per share	Grant	Acquire A	No	No	5,075	26,287
15 Jun 22	Levine Joshua	Common Stock, $0.001 par value per share	Grant	Acquire A	No	No	5,075	37,387
15 Jun 22	Bryant M Moore	Common Stock, $0.001 par value per share	Grant	Acquire A	No	No	4,315	10,114

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

NTUS institutional ownership history Ownership history

92.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	166	170	-2.4%
Opened positions	13	19	-31.6%
Closed positions	17	13	+30.8%
Increased positions	65	60	+8.3%
Reduced positions	59	62	-4.8%

13F shares	Current	Prev Q	Change
Total value	838.95M	3.41B	-75.4%
Total shares	31.96M	31.74M	+0.7%
Total puts	0	0
Total calls	0	10K	EXIT
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
BLK Blackrock	6.51M	$170.99M	-0.8%
Vanguard	3.06M	$80.39M	+0.5%
Victory Capital Management	2.64M	$69.68M	+7.8%
Allspring Global Investments	2.1M	$55.11M	+15.2%
Dimensional Fund Advisors	1.4M	$36.76M	+6.2%
STT State Street	1.35M	$35.36M	+2.0%
JHG Janus Henderson	1.16M	$30.51M	+8.0%
AMP Ameriprise Financial	1.12M	$29.39M	+23.3%
Nuveen Asset Management	811.22K	$20.47M	-1.1%
JPM JPMorgan Chase & Co.	635.94K	$16.71M	-6.9%

Largest transactions	Shares	Bought/sold	Change
Wellington Management	0	-298.76K	EXIT
Norges Bank	0	-277.4K	EXIT
Allspring Global Investments	2.1M	+276K	+15.2%
Kent Lake Capital	215K	+215K	NEW
AMP Ameriprise Financial	1.12M	+211.85K	+23.3%
IPXAF Impax Asset Management	456.05K	-200K	-30.5%
Victory Capital Management	2.64M	+190.05K	+7.8%
Arrowstreet Capital, Limited Partnership	286.76K	-113.96K	-28.4%
Jupiter Asset Management	141.06K	+107.75K	+323.5%
GS Goldman Sachs	499.82K	-104.19K	-17.2%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Integra Lifesciences • Neurometrix

Risks

The Company is subject to business uncertainties, litigation risk and contractual restrictions while the Merger is pending, which may adversely affect our business, financial condition and results of operations.
Failure to consummate the proposed Merger within the expected timeframe or at all could negatively impact the price of our common stock, as well as our business, financial condition and results of operations.
The Company's ability to complete the Merger is subject to certain closing conditions and the receipt of consents and approvals from government entities which may impose conditions that could adversely affect the Company or cause the Merger to be abandoned.
The ongoing conflict between Russia and Ukraine has impacted our results of operations and could create or exacerbate certain risks we face to our business, financial condition and results of operations.

Management Discussion

Our business and operating results are driven in part by worldwide economic conditions. Our revenue is significantly dependent on both capital spending by hospitals in the United States and healthcare spending by ministries of health outside the United States. While we have no direct exposure to Russia and Ukraine, we are monitoring any broader economic impact from the current crisis, especially on commodities.
We experienced an increase in demand in the United States and Europe, during the first quarter compared to the same period in the prior year. Our consolidated revenue for the first quarter ended March 31, 2022 was $119.8 million compared to $114.9 million in the first quarter of the previous year, an increase of $4.9 million.
Our net income was $1.9 million or $0.06 per diluted share in the three months ended March 31, 2022, compared with net income of $2.4 million or $0.07 per diluted share in the same period in 2021. The decrease in net

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abandoned, abandonment, absence, accelerate, achieved, achievement, acquisition, acute, addressed, agreed, ALGO, alternative, anniversary, antitrust, appraisal, approval, April, attained, attract, Aurical, automatically, body, broader, Camino, cancelled, capture, carpal, carryback, case, CEO, Christopher, Chung, Codification, compensatory, complement, comprised, concurrently, conflict, consummate, consummated, consummation, contemplated, convened, converted, correct, cumulative, Cut, Dantec, death, deemed, degree, Delaware, diagnose, diagnosing, Digital, disability, disease, dystonia, economy, education, EEG, elapsed, Elite, Embla, EMG, enacted, enactment, encourage, energy, enjoining, entitled, escalation, exacerbate, exacerbated, exercise, experimental, expiration, extinguished, face, facing, failed, fashion, favorable, fee, fifteen, forfeit, forfeited, forfeiture, geopolitical, GILTI, good, hardware, hemorrhagic, imposition, impression, inability, inclusion, incurrence, inflation, innovative, intensified, invasion, IRC, issuable, January, large, legislation, life, litigation, low, macroeconomic, Madsen, magnitude, mandatory, maximum, merger, Mergerco, modified, motivate, movement, multiplied, muscle, myasthenia, nature, NCS, neoBLUE, nerve, neural, Nicolet, NICU, notwithstanding, null, Olympic, option, Otoscan, par, Parent, Parkinson, pediatric, pendency, pending, perfected, peripheral, personnel, physiological, pinched, premature, prematurity, President, Prince, procuring, professional, prohibiting, prolonged, prorated, PSG, pursue, Quantum, raw, receipt, regular, relevant, repealed, restraining, retain, retaliatory, RetCam, retention, retinopathy, Russia, satisfied, stabilize, stemming, streaming, stroke, Subpart, subsidiary, Sullivan, Superior, surviving, syndrome, target, temperature, testing, thereof, thereon, thereto, treasury, treat, treated, treating, trend, Trex, true, trusted, tunnel, Ukraine, UltraPro, unconditional, understanding, undertaken, variety, vertigo, vest, vested, vesting, video, void, waiting, waived, Xltek

Removed: account, adapting, ahead, AOCI, arrange, assessed, assured, audiological, borrow, category, central, collaboration, collected, context, COVID, cranial, declared, delayed, derivative, diagnostic, diverse, Emergency, enabled, enhance, entry, environment, established, evaluating, exiting, extensive, external, field, firm, forced, forecasted, geographically, growth, handle, hedge, incident, instrumentation, Intensive, interruption, intraoperative, involving, Jonathan, Kennedy, laboratory, mitigation, model, mutually, Neuro, neurological, neurosurgery, online, onset, Organization, otoneurologic, partner, payroll, Pediatrix, Peloton, persist, policy, precaution, preceding, presence, prioritize, profitable, program, reclassified, recognition, recommended, record, recovery, recur, reliably, relief, repaid, repurchase, schedule, scope, seek, sensitive, serve, shift, size, small, sophisticated, stated, strategy, strong, Subsidy, surgical, swap, typically, unknown, unrealized, valuation, varying, Wage, worked

From filing 10-Q 2022 Q1

Financial reports

View all